BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21851459)

  • 1. Tachyphylaxis/tolerance to antidepressants in treatment of dysthymia: results of a retrospective naturalistic chart review study.
    Katz G
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):499-504. PubMed ID: 21851459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.
    Posternak MA; Zimmerman M
    J Clin Psychiatry; 2005 Jun; 66(6):705-7. PubMed ID: 15960562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review.
    Quagliato LA; Primavera D; Fornaro M; Preti A; Carta MG; Nardi AE
    Expert Opin Pharmacother; 2023; 24(18):2035-2040. PubMed ID: 37787056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
    Heiser P; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of dysthymia.
    Buni TM
    J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs versus placebo for dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of drugs versus placebo for the treatment of dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models.
    Ballesteros J
    J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants.
    Lee K; Baron K; Soca R; Attarian H
    J Clin Sleep Med; 2016 Mar; 12(3):351-5. PubMed ID: 26446247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased chin muscle tone during all sleep stages in children taking selective serotonin reuptake inhibitor antidepressants and in children with narcolepsy type 1.
    Ferri R; Mogavero MP; Bruni O; Plazzi G; Schenck CH; DelRosso LM
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34111296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms.
    Aleksovski B; Neceva V; Vujović V; Manusheva N; Rendevski V; Novotni A; Filipce A; Spasovska A; Sofijanova A; Aleksovski V; Gjorgoski I
    Thromb Res; 2018 May; 165():24-32. PubMed ID: 29549779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRI-associated sexual dysfunction.
    Balon R
    Am J Psychiatry; 2006 Sep; 163(9):1504-9; quiz 1664. PubMed ID: 16946173
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
    Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
    Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.